Matthew Winkler, Director at Akoya Biosciences, Inc. (AKYA), bought 203,388 shares at $5.00 ($1.0M) on 2023-06-12, disclosed to the SEC on 2023-06-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.